Anne M. McIntosh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anne M. McIntosh has a total of 158 co-authors. Here are the top co-authors by number of shared publications:
- Samuel F. Berkovic
Epilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, VIC 3084, Australia
28 shared publications - Terence John O'BRien
Department of Neuroscience, School of Translational Medicine Monash University Melbourne Victoria Australia
10 shared publications - Sarah J. Wilson
Melbourne School of Psychological Sciences The University of Melbourne Melbourne Victoria Australia
8 shared publications - Piero Perucca
Department of Medicine (Austin Health) The University of Melbourne Melbourne Victoria Australia
7 shared publications - Honor Coleman
Epilepsy Research Centre, Department of Medicine (Austin Health), University of Melbourne, Australia; School of Clinical Sciences, Monash University, Australia; Melbourne School of Psychological Sciences, The University of Melbourne, Australia
6 shared publications - Graeme D. Jackson
Bladin‐Berkovic Comprehensive Epilepsy Program, Department of Neurology Austin Health Melbourne Victoria Australia
5 shared publications
Latest Publications
- Open Access
- 12 September 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 185
Mortality in two independent First Seizure Clinic cohorts up to 20 years post epilepsy diagnosis
- 12 September 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 185
Open AccessMortality in two independent First Seizure Clinic cohorts up to 20 years post epilepsy diagnosis
- 22 January 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 176, 110864
Delay to diagnosis of epilepsy: A history of a psychiatric disorder and substance use is associated with prior seizures
- 22 January 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 176, 110864
Delay to diagnosis of epilepsy: A history of a psychiatric disorder and substance use is associated with prior seizures
- 22 November 2022
- Published by Elsevier in Epilepsy & Behavior
- Vol. 138, 108960
Comorbidities in newly diagnosed epilepsy: Pre-existing health conditions are common and complex across age groups
- 22 November 2022
- Published by Elsevier in Epilepsy & Behavior
- Vol. 138, 108960
Comorbidities in newly diagnosed epilepsy: Pre-existing health conditions are common and complex across age groups
- Open Access
Extended follow‐up after anterior temporal lobectomy demonstrates seizure recurrence 20+ years postsurgery
Objective: Anterior temporal lobectomy (ATL) for medication‐resistant localized epilepsy results in ablation or reduction of seizures for most patients. However, some individuals who attain an initial extended period of postsurgical seizure freedom will experience a later seizure recurrence. In this study, we examined the prevalence and some risk factors for late recurrence in an ATL cohort with extensive regular follow‐up.Methods: Included were 449 patients who underwent ATL at Austin Health, Australia, from 1978 to 2008. Postsurgical follow‐up was undertaken 2–3 yearly. Seizure recurrence was tested using Kaplan–Meier analysis, log‐rank test, and Cox regression. Late recurrence was qualified as a first disabling seizure >2 years postsurgery. We examined risks within the ATL cohort according to broad pathology groups and tested whether late recurrence differed for the ATL cohort compared to patients who had resections outside the temporal lobe (n = 98).Results: Median post‐ATL follow‐up was 22 years (range = .1–38.6), 6% were lost to follow‐up, and 12% had died. Probabilities for remaining completely seizure‐free after surgery were 51% (95% confidence interval [CI] = 53–63) at 2 postoperative years, 36% (95% CI = 32–41) at 10 years, 32% (95% CI = 27–36) at 20 years, and 30% (95% CI = 25–34) at 25 years. Recurrences were reported up to 23 years postoperatively. Late seizures occurred in all major ATL pathology groups, with increased risk in the "normal" and "distant lesion" groups (p ≤ .03). Comparison between the ATL cohort and patients who underwent extratemporal resection demonstrated similar patterns of late recurrence (p = .74).Significance: Some first recurrences were very late, reported decades after ATL. Late recurrences were not unique to any broad ATL pathology group and did not differ according to whether resections were ATL or extratemporal. Reports of these events by patients with residual pathology suggest that potentially epileptogenic abnormalities outside the area of resection may be implicated as one of several possible underlying mechanisms.
Open AccessExtended follow‐up after anterior temporal lobectomy demonstrates seizure recurrence 20+ years postsurgery
Objective: Anterior temporal lobectomy (ATL) for medication‐resistant localized epilepsy results in ablation or reduction of seizures for most patients. However, some individuals who attain an initial extended period of postsurgical seizure freedom will experience a later seizure recurrence. In this study, we examined the prevalence and some risk factors for late recurrence in an ATL cohort with extensive regular follow‐up.Methods: Included were 449 patients who underwent ATL at Austin Health, Australia, from 1978 to 2008. Postsurgical follow‐up was undertaken 2–3 yearly. Seizure recurrence was tested using Kaplan–Meier analysis, log‐rank test, and Cox regression. Late recurrence was qualified as a first disabling seizure >2 years postsurgery. We examined risks within the ATL cohort according to broad pathology groups and tested whether late recurrence differed for the ATL cohort compared to patients who had resections outside the temporal lobe (n = 98).Results: Median post‐ATL follow‐up was 22 years (range = .1–38.6), 6% were lost to follow‐up, and 12% had died. Probabilities for remaining completely seizure‐free after surgery were 51% (95% confidence interval [CI] = 53–63) at 2 postoperative years, 36% (95% CI = 32–41) at 10 years, 32% (95% CI = 27–36) at 20 years, and 30% (95% CI = 25–34) at 25 years. Recurrences were reported up to 23 years postoperatively. Late seizures occurred in all major ATL pathology groups, with increased risk in the "normal" and "distant lesion" groups (p ≤ .03). Comparison between the ATL cohort and patients who underwent extratemporal resection demonstrated similar patterns of late recurrence (p = .74).Significance: Some first recurrences were very late, reported decades after ATL. Late recurrences were not unique to any broad ATL pathology group and did not differ according to whether resections were ATL or extratemporal. Reports of these events by patients with residual pathology suggest that potentially epileptogenic abnormalities outside the area of resection may be implicated as one of several possible underlying mechanisms.
- 11 February 2022
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 96, 121-127
Diagnostic delay in focal epilepsy: Association with brain pathology and age
- 11 February 2022
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 96, 121-127
Diagnostic delay in focal epilepsy: Association with brain pathology and age
“Do I still have epilepsy?” Epilepsy identity 15–20 years after anterior temporal lobectomy
Objective: Identity is a multifaceted construct, comprising personal identity (sense of being a unique individual) and social identity (the sense‐of‐self derived from membership of social groups). Social identity involves explicit identification with a group (“I am …”) and implicit behaviors or attitudes associated with group membership. Following successful treatment with surgery, patients with epilepsy can undergo a complex and lasting change in personal identity. To date, there has been no research into postoperative social epilepsy identity (SEI). We sought to examine SEI 15–20 years post‐surgery, and the relationship between SEI and satisfaction with surgery, psychosocial improvements, mood, and health‐related quality of life (HRQoL).Methods: Thirty‐two patients who underwent anterior temporal lobectomy (ATL; 19 female) were recruited, with a median follow‐up of 18 years (interquartile range [IQR] = 2.5). Using a novel interactive online program, we collected data on SEI, satisfaction with surgery, and perceived psychosocial improvements, alongside standardized measures of mood (Neurological Disorders Depressio Inventory‐Epilepsy; Patient Health Questionnaire‐Generalised Anxiety Disorder‐7 item) and HRQoL (Quality of Life in Epilepsy‐31 item). Non‐parametric analyses were used to analyse the data.Results: Twenty‐five percent of patients were free of disabling seizures since surgery, yet 65% stated they no longer had epilepsy and >90% reported satisfaction with surgery. Explicitly discarding SEI was positively associated with HRQoL at long‐term follow‐up, over and above seizure outcome. Implicit SEI was expressed as (a) acceptance of epilepsy, (b) a sense of belonging to the epilepsy community, and (c) difficulty disclosing and discussing epilepsy. Difficulty disclosing and discussing epilepsy was associated with increased anxiety and lower HRQoL.Significance: At long‐term follow‐up, over half of our patients reported an explicit change in SEI, which could promote better HRQoL. In contrast, difficulty with disclosure of epilepsy was associated with increased anxiety and reduced HRQoL, possibly reflecting the ongoing effects of stigma. These findings highlight the importance of understanding changes in patient social identity for promoting long‐term well‐being after surgery.
“Do I still have epilepsy?” Epilepsy identity 15–20 years after anterior temporal lobectomy
Objective: Identity is a multifaceted construct, comprising personal identity (sense of being a unique individual) and social identity (the sense‐of‐self derived from membership of social groups). Social identity involves explicit identification with a group (“I am …”) and implicit behaviors or attitudes associated with group membership. Following successful treatment with surgery, patients with epilepsy can undergo a complex and lasting change in personal identity. To date, there has been no research into postoperative social epilepsy identity (SEI). We sought to examine SEI 15–20 years post‐surgery, and the relationship between SEI and satisfaction with surgery, psychosocial improvements, mood, and health‐related quality of life (HRQoL).Methods: Thirty‐two patients who underwent anterior temporal lobectomy (ATL; 19 female) were recruited, with a median follow‐up of 18 years (interquartile range [IQR] = 2.5). Using a novel interactive online program, we collected data on SEI, satisfaction with surgery, and perceived psychosocial improvements, alongside standardized measures of mood (Neurological Disorders Depressio Inventory‐Epilepsy; Patient Health Questionnaire‐Generalised Anxiety Disorder‐7 item) and HRQoL (Quality of Life in Epilepsy‐31 item). Non‐parametric analyses were used to analyse the data.Results: Twenty‐five percent of patients were free of disabling seizures since surgery, yet 65% stated they no longer had epilepsy and >90% reported satisfaction with surgery. Explicitly discarding SEI was positively associated with HRQoL at long‐term follow‐up, over and above seizure outcome. Implicit SEI was expressed as (a) acceptance of epilepsy, (b) a sense of belonging to the epilepsy community, and (c) difficulty disclosing and discussing epilepsy. Difficulty disclosing and discussing epilepsy was associated with increased anxiety and lower HRQoL.Significance: At long‐term follow‐up, over half of our patients reported an explicit change in SEI, which could promote better HRQoL. In contrast, difficulty with disclosure of epilepsy was associated with increased anxiety and reduced HRQoL, possibly reflecting the ongoing effects of stigma. These findings highlight the importance of understanding changes in patient social identity for promoting long‐term well‐being after surgery.
Understanding long‐term changes in patient identity 15–20 years after surgery for temporal lobe epilepsy
Objective: Following epilepsy surgery, patients can experience complex psychosocial changes. We recently described a longer term adjustment and reframing (“meaning‐making”) process 15–20 years following surgery for temporal lobe epilepsy, which could involve an ongoing sense of being a “different” person for some patients. Here, we quantitatively examine identity at long‐term follow‐up and how this relates to meaning‐making and postoperative seizure outcome.Methods: Eighty‐seven participants were included: 39 who underwent anterior temporal lobectomy (ATL) 15–20 years ago (59% female; median age = 49.2 years, interquartile range [IQR] = 10; median follow‐up = 18.4 years, IQR = 4.4) and 48 surgically naïve focal epilepsy patients (56% female; median age = 34.5 years, IQR = 19). We captured approach to meaning‐making by coding for key narrative features identified in our previous qualitative work. Nonparametric tests and correspondence analysis were then used to explore relationships between a quantitative measure of identity and meaning‐making, as well as seizure outcome, mood, and health‐related quality of life (HRQOL).Results: Patients 15–20 years post‐ATL demonstrated a shift toward increasing identity commitment and exploration compared to the surgically naïve cohort, with this shift significantly linked to seizure outcome. Examining the relationship between identity and meaning‐making also revealed three groups: (1) those who embraced self‐change (29%), (2) those who continued to struggle with this process (60.5%), and (3) those who showed minimal engagement (10.5%). Those who "embraced change" were significantly younger at regular seizure onset and demonstrated a trend toward higher HRQOL.Significance: Findings suggest that ATL patients show a more developed identity profile compared to surgically naïve controls; however, the majority still struggled with postoperative identity change at long‐term follow‐up. Approximately one third of patients demonstrated positive psychological growth following surgery, reflected in the ability to embrace change. Findings highlight the importance of understanding the impact of surgery on patient identity to maximize the psychosocial benefits.
Understanding long‐term changes in patient identity 15–20 years after surgery for temporal lobe epilepsy
Objective: Following epilepsy surgery, patients can experience complex psychosocial changes. We recently described a longer term adjustment and reframing (“meaning‐making”) process 15–20 years following surgery for temporal lobe epilepsy, which could involve an ongoing sense of being a “different” person for some patients. Here, we quantitatively examine identity at long‐term follow‐up and how this relates to meaning‐making and postoperative seizure outcome.Methods: Eighty‐seven participants were included: 39 who underwent anterior temporal lobectomy (ATL) 15–20 years ago (59% female; median age = 49.2 years, interquartile range [IQR] = 10; median follow‐up = 18.4 years, IQR = 4.4) and 48 surgically naïve focal epilepsy patients (56% female; median age = 34.5 years, IQR = 19). We captured approach to meaning‐making by coding for key narrative features identified in our previous qualitative work. Nonparametric tests and correspondence analysis were then used to explore relationships between a quantitative measure of identity and meaning‐making, as well as seizure outcome, mood, and health‐related quality of life (HRQOL).Results: Patients 15–20 years post‐ATL demonstrated a shift toward increasing identity commitment and exploration compared to the surgically naïve cohort, with this shift significantly linked to seizure outcome. Examining the relationship between identity and meaning‐making also revealed three groups: (1) those who embraced self‐change (29%), (2) those who continued to struggle with this process (60.5%), and (3) those who showed minimal engagement (10.5%). Those who "embraced change" were significantly younger at regular seizure onset and demonstrated a trend toward higher HRQOL.Significance: Findings suggest that ATL patients show a more developed identity profile compared to surgically naïve controls; however, the majority still struggled with postoperative identity change at long‐term follow‐up. Approximately one third of patients demonstrated positive psychological growth following surgery, reflected in the ability to embrace change. Findings highlight the importance of understanding the impact of surgery on patient identity to maximize the psychosocial benefits.
Missed, mistaken, stalled: Identifying components of delay to diagnosis in epilepsy
A substantial proportion of individuals with newly diagnosed epilepsy report prior seizures, suggesting a missed opportunity for early epilepsy care and management. Consideration of the causes and outcomes of diagnostic delay is needed to address this issue. We aimed to review the literature pertaining to delay to diagnosis of epilepsy, describing the components, characteristics, and risk factors for delay. We undertook a systematic search of the literature for full‐length original research papers with a focus on diagnostic delay or seizures before diagnosis, published 1998–2020. Findings were collated, and a narrative review was undertaken. Seventeen papers met the inclusion criteria. Studies utilized two measures of diagnostic delay: seizures before diagnosis and/or a study‐defined time between first seizure and presentation/diagnosis. The proportion of patients with diagnostic delay ranged from 16% to 77%; 75% of studies reported 38% or more to be affected. Delays of 1 year or more were reported in 13%–16% of patients. Seizures prior to diagnosis were predominantly nonconvulsive, and usually more than one seizure was reported. Prior seizures were often missed or mistaken for symptoms of other conditions. Key delays in the progression to specialist review and diagnosis were (1) “decision delay” (the patient's decision to seek/not seek medical review), (2) “referral delay” (delay by primary care/emergency physician referring to specialist), and (3) “attendance delay” (delay in attending specialist review). There were few data available relevant to risk factors and virtually none relevant to outcomes of diagnostic delay. This review found that diagnostic delay consists of several components, and progression to diagnosis can stall at several points. There is limited information relating to most aspects of delay apart from prevalence and seizure types. Risk factors and outcomes may differ according to delay characteristics and for each of the key delays, and recommendations for future research include examining each before consideration of interventions is made.
Missed, mistaken, stalled: Identifying components of delay to diagnosis in epilepsy
A substantial proportion of individuals with newly diagnosed epilepsy report prior seizures, suggesting a missed opportunity for early epilepsy care and management. Consideration of the causes and outcomes of diagnostic delay is needed to address this issue. We aimed to review the literature pertaining to delay to diagnosis of epilepsy, describing the components, characteristics, and risk factors for delay. We undertook a systematic search of the literature for full‐length original research papers with a focus on diagnostic delay or seizures before diagnosis, published 1998–2020. Findings were collated, and a narrative review was undertaken. Seventeen papers met the inclusion criteria. Studies utilized two measures of diagnostic delay: seizures before diagnosis and/or a study‐defined time between first seizure and presentation/diagnosis. The proportion of patients with diagnostic delay ranged from 16% to 77%; 75% of studies reported 38% or more to be affected. Delays of 1 year or more were reported in 13%–16% of patients. Seizures prior to diagnosis were predominantly nonconvulsive, and usually more than one seizure was reported. Prior seizures were often missed or mistaken for symptoms of other conditions. Key delays in the progression to specialist review and diagnosis were (1) “decision delay” (the patient's decision to seek/not seek medical review), (2) “referral delay” (delay by primary care/emergency physician referring to specialist), and (3) “attendance delay” (delay in attending specialist review). There were few data available relevant to risk factors and virtually none relevant to outcomes of diagnostic delay. This review found that diagnostic delay consists of several components, and progression to diagnosis can stall at several points. There is limited information relating to most aspects of delay apart from prevalence and seizure types. Risk factors and outcomes may differ according to delay characteristics and for each of the key delays, and recommendations for future research include examining each before consideration of interventions is made.
- Open Access
- 16 December 2020
- Published by Wiley in Epilepsia Open
- Vol. 6 (1) , 171-180
Newly diagnosed seizures assessed at two established first seizure clinics: Clinic characteristics, investigations, and findings over 11 years
Objective: ‘First seizure’ clinics (FSCs) aim to achieve early expert assessment for individuals with possible new‐onset epilepsy. These clinics also have substantial potential for research into epilepsy evolution, outcomes, and costs. However, a paucity of FSCs details has implications for interpretation and utilization of this research.Methods: We reviewed investigation findings over 11 years (2000‐2010) from two established independent FSCs at Austin Health (AH) and Royal Melbourne Hospital (RMH), Australia. These adult clinics are in major public hospitals and operate with similar levels of expertise. Organizational differences include screening and dedicated administration at AH. Included were N = 1555 patients diagnosed with new‐onset unprovoked seizures/epilepsy (AH n = 901, RMH n = 654). Protocol‐driven interviews and investigations had been recorded prospectively and were extracted from medical records for study.Results: Median patient age was 37 (IQR 26‐52, range 18‐94) years (AH 34 vs RMH 42 years; P < .001). Eighty‐six percent of patients attended FSC within three weeks postindex seizure (median AH 12 vs RMH 25 days; P < .01). By their first appointment, 42% had experienced ≥2 seizures. An EEG was obtained within three weeks postindex seizure in 73% of patients, demonstrating epileptiform discharges in 25% (AH 33% vs RMH 15%). Seventy‐six percent of patients had an MRI within 6 weeks. Of those with imaging (n = 1500), 19% had potentially epileptogenic abnormalities (RMH 28% vs AH 12%; P < .01). At both sites, changes due to previous stroke/hemorrhage were the commonest lesions, followed by traumatic brain injury. ≥WHO level 1 brain tumors diagnosed at presentation comprised a very small proportion (<1%) at each clinic. At both sites, epilepsy type could be determined in 60% of patients; RMH had more focal and AH more generalized epilepsy diagnoses.Significance: Differences between the clinics’ administrative and screening practices may contribute to differences in investigation findings. Insight into these differences will facilitate interpretation and utilization, and planning of future research.
- 16 December 2020
- Published by Wiley in Epilepsia Open
- Vol. 6 (1) , 171-180
Open AccessNewly diagnosed seizures assessed at two established first seizure clinics: Clinic characteristics, investigations, and findings over 11 years
Objective: ‘First seizure’ clinics (FSCs) aim to achieve early expert assessment for individuals with possible new‐onset epilepsy. These clinics also have substantial potential for research into epilepsy evolution, outcomes, and costs. However, a paucity of FSCs details has implications for interpretation and utilization of this research.Methods: We reviewed investigation findings over 11 years (2000‐2010) from two established independent FSCs at Austin Health (AH) and Royal Melbourne Hospital (RMH), Australia. These adult clinics are in major public hospitals and operate with similar levels of expertise. Organizational differences include screening and dedicated administration at AH. Included were N = 1555 patients diagnosed with new‐onset unprovoked seizures/epilepsy (AH n = 901, RMH n = 654). Protocol‐driven interviews and investigations had been recorded prospectively and were extracted from medical records for study.Results: Median patient age was 37 (IQR 26‐52, range 18‐94) years (AH 34 vs RMH 42 years; P < .001). Eighty‐six percent of patients attended FSC within three weeks postindex seizure (median AH 12 vs RMH 25 days; P < .01). By their first appointment, 42% had experienced ≥2 seizures. An EEG was obtained within three weeks postindex seizure in 73% of patients, demonstrating epileptiform discharges in 25% (AH 33% vs RMH 15%). Seventy‐six percent of patients had an MRI within 6 weeks. Of those with imaging (n = 1500), 19% had potentially epileptogenic abnormalities (RMH 28% vs AH 12%; P < .01). At both sites, changes due to previous stroke/hemorrhage were the commonest lesions, followed by traumatic brain injury. ≥WHO level 1 brain tumors diagnosed at presentation comprised a very small proportion (<1%) at each clinic. At both sites, epilepsy type could be determined in 60% of patients; RMH had more focal and AH more generalized epilepsy diagnoses.Significance: Differences between the clinics’ administrative and screening practices may contribute to differences in investigation findings. Insight into these differences will facilitate interpretation and utilization, and planning of future research.
- 11 August 2020
- Published by Wolters Kluwer Health in Neurology
- Vol. 95 (6) , e643-e652
Mortality in patients with psychogenic nonepileptic seizures
Objective To investigate the hypothesis that patients diagnosed with psychogenic nonepileptic seizures (PNES) on video-EEG monitoring (VEM) have increased mortality by comparison to the general population. Methods This retrospective cohort study included patients evaluated in VEM units of 3 tertiary hospitals in Melbourne, Australia, between January 1, 1995, and December 31, 2015. Diagnosis was based on consensus opinion of experienced epileptologists and neuropsychiatrists at each hospital. Mortality was determined in patients diagnosed with PNES, epilepsy, or both conditions by linkage to the Australian National Death Index. Lifetime history of psychiatric disorders in PNES was determined from formal neuropsychiatric reports. Results A total of 5,508 patients underwent VEM. A total of 674 (12.2%) were diagnosed with PNES, 3064 (55.6%) with epilepsy, 175 (3.2%) with both conditions, and 1,595 (29.0%) received other diagnoses or had no diagnosis made. The standardized mortality ratio (SMR) of patients diagnosed with PNES was 2.5 (95% confidence interval [CI] 2.0–3.3). Those younger than 30 had an 8-fold higher risk of death (95% CI 3.4–19.8). Direct comparison revealed no significant difference in mortality rate between diagnostic groups. Among deaths in patients diagnosed with PNES (n = 55), external causes contributed 18%, with 20% of deaths in those younger than 50 years attributed to suicide, and “epilepsy” was recorded as the cause of death in 24%. Conclusions Patients diagnosed with PNES have a SMR 2.5 times above the general population, dying at a rate comparable to those with drug-resistant epilepsy. This emphasizes the importance of prompt diagnosis, identification of risk factors, and implementation of appropriate strategies to prevent potential avoidable deaths.
- 11 August 2020
- Published by Wolters Kluwer Health in Neurology
- Vol. 95 (6) , e643-e652
Mortality in patients with psychogenic nonepileptic seizures
Objective To investigate the hypothesis that patients diagnosed with psychogenic nonepileptic seizures (PNES) on video-EEG monitoring (VEM) have increased mortality by comparison to the general population. Methods This retrospective cohort study included patients evaluated in VEM units of 3 tertiary hospitals in Melbourne, Australia, between January 1, 1995, and December 31, 2015. Diagnosis was based on consensus opinion of experienced epileptologists and neuropsychiatrists at each hospital. Mortality was determined in patients diagnosed with PNES, epilepsy, or both conditions by linkage to the Australian National Death Index. Lifetime history of psychiatric disorders in PNES was determined from formal neuropsychiatric reports. Results A total of 5,508 patients underwent VEM. A total of 674 (12.2%) were diagnosed with PNES, 3064 (55.6%) with epilepsy, 175 (3.2%) with both conditions, and 1,595 (29.0%) received other diagnoses or had no diagnosis made. The standardized mortality ratio (SMR) of patients diagnosed with PNES was 2.5 (95% confidence interval [CI] 2.0–3.3). Those younger than 30 had an 8-fold higher risk of death (95% CI 3.4–19.8). Direct comparison revealed no significant difference in mortality rate between diagnostic groups. Among deaths in patients diagnosed with PNES (n = 55), external causes contributed 18%, with 20% of deaths in those younger than 50 years attributed to suicide, and “epilepsy” was recorded as the cause of death in 24%. Conclusions Patients diagnosed with PNES have a SMR 2.5 times above the general population, dying at a rate comparable to those with drug-resistant epilepsy. This emphasizes the importance of prompt diagnosis, identification of risk factors, and implementation of appropriate strategies to prevent potential avoidable deaths.